CEO of Fluofarma, Jean-Baptiste Pin has over 10 years experience in the
pharmaceutical and biotechnology industries in the areas of general management
and business development. Before joining Fluofarma, he was a Senior Consultant
at Ernst & Young specializing in biotechnology.
Dr François Ichas is the scientific director of Fluofarma and brings a strong expertise in cell biology and cell-based assays design. Dr Ichas holds a PhD in Biomedical Sciences (1997) followed by several post-doctoral positions as well as a Group Leader Fellowship at the European Institute of Chemistry and Biology. He co-authored over 40 peer-reviewed scientific publications and patents. Dr Ichas is co-founder of Fluofarma, and as INSERM Research Director, is in charge of promoting and organizing new translational & interdisciplinary research axes at the INSERM Apoptosis and Cancer laboratory U916 VINCO.
Project manager at Fluofarma, Loïc plays a key role in managing the relationship
between our scientist team and our clients. He is also responsible for the
supervision of Fluofarma European projects.
Julie is responsible for the commercial development of the company by canvassing
new customers,managing commercial negotiations and maintainings the
customer relationship through the order-taking process. She is mainly responsible
for academics and biotech accounts in Europe. Before joining the company, she
worked as a Licensing Officer for Avenium Consulting, a technology transfer
office.